Synarc’s in-house medical directors and scientific experts are the leading authorities in the use of medical imaging and biochemical markers in drug development, and have helped develop many methods currently used in clinical trials for osteoporosis.

	Harry K. Genant, M.D. Chairman, Emeritus Co-founder of Synarc			Thomas Fuerst, PhD. Scientific Director, Osteoporosis
	Patrick Garnero, Ph.D., D.Sc. Vice President and General Manger, Biochemical Markers			Kenneth G. Faulkner, Ph.D. Vice President of Scientific Services